Skip to search formSkip to main contentSkip to account menu

Vepesid

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
The development of topotecan (Hycamtin) and the encouraging preliminary results of its use in clinical trials are comprehensively… 
2007
2007
Maligne Lymphomerkrankungen stellen lebensgefahrliche Krankheitsbilder dar. Auch wenn mit der ersten Therapie nach… 
2006
2006
We investigated 79 patients (76.0%) with lymphosarcoma of abdominal lymph nodes among all 104 with general abdominal… 
2004
2004
A total of 23 advanced gastric cancer patients older than 65 years received 500 mg/m2 5-fluorouracil i.v. on days 2–4, 120 mg/m2… 
2004
2004
We report on the unintended overdosing of Vepesid in a patient with Hodgkin's disease. K. N., a 25-year-old woman, was diagnosed… 
2002
2002
Objective: Vepesid is a semisynthetic derivative of phodophylotoxin extracted from Phodophylum peltatum, which is in the group of… 
1989
1989
Six cell lines were derived from pleural effusions of two lung cancer patients and established in vitro in our laboratory. Cell… 
1985
1985
The authors present seven typical cases chosen from a group of thirty patients with recurrent Hodgkin's disease. One out of these… 
1981
1981
Advanced malignant testicular tumors can be treated very successfully by chemotherapy. The most effective 3 or 4-drug…